ICON Reports Mixed Q1 2026: Strong Bookings Offset by Revenue Decline
Event summary
- ICON reported net bookings of $2.9 billion in Q1 2026, with a net book-to-bill ratio of 1.42.
- Revenue increased by 0.9% year-over-year but decreased by 1.9% on a constant currency basis to $2.03 billion.
- Adjusted EBITDA fell by 20.2% year-over-year to $317.7 million, or 15.6% of revenue.
- Free cash flow was $136.2 million, with cash and cash equivalents increasing to $765.2 million.
The big picture
ICON's Q1 2026 results highlight a tension between strong commercial momentum and revenue challenges. The company's robust net bookings and improved win rates suggest sustained demand for its clinical research services, but the decline in adjusted EBITDA and constant currency revenue indicates operational hurdles. As the healthcare sector continues to evolve with increasing regulatory scrutiny and competitive pressures, ICON's ability to execute its strategic plan will be critical.
What we're watching
- Revenue Mix Impact
- How ICON's business mix will affect its financial performance throughout 2026.
- Strategic Partnerships
- Whether the addition of new partnerships can sustain improved win rates and commercial momentum.
- Cost Management
- The pace at which ICON can control costs to improve its EBITDA margin.
Related topics